NutriStack
Medical review must be real and named.
NutriStack does not claim that its public research library has received blanket review by a physician, pharmacist, dietitian, or other licensed clinician.
Current status
What is and is not reviewed today.
The honest default is compiled-only.
No blanket review
Current state. The qualified-human review ledger is empty. No generated supplement, prescription, interaction, symptom, goal, form, protocol, dose, depletion, or claim page is currently approved for search indexing. Those records remain available as an explicitly exploratory catalog while the evidence and safety review is completed.
A disclaimer, evidence badge, citation count, software check, AI-assisted review, or team update does not count as medical review.
Review standard
When NutriStack may say medically reviewed.
A review claim requires evidence of the review, not a decorative badge.
Required record
- Named reviewer. The reviewer must be a real person whose credential and scope match the subject, such as a pharmacist for medication interactions or an appropriately qualified physician or dietitian for the relevant clinical topic.
- Defined scope. The review record must identify the exact page and the material reviewed, including safety, dosing, contraindications, uncertainty, and source interpretation where applicable.
- Immutable reviewed version. Approval must be bound to the content and source hash that the reviewer actually saw, with direct sources for the verdict, dose, contrary evidence, and safety claims. A material data or template change invalidates that approval until re-review.
- Conflicts disclosed. The reviewer record must state relevant financial or professional conflicts, or explicitly record that none were disclosed.
- Real date and accountability. The visible review date must be the date the review occurred, not a build date. The reviewer profile and any relevant disclosures must be public.
- Re-review after material change. A material medical change can make the prior review stale. The page must not imply that new material was reviewed until the reviewer evaluates it.
Priority
Which pages need expert review first.
Risk and potential user harm determine the sequence.
High-risk cohorts
- Medication and supplement interaction guidance, especially contraindications, dose changes, monitoring thresholds, and timing instructions.
- Disease, symptom, pregnancy, pediatric, emergency, mental-health, anticoagulation, cardiovascular, renal, hepatic, and other high-risk YMYL content.
- Pages that recommend a protocol, dose, product combination, or action that could change care.
- Claims or reports used for professional outreach or presented as original interpretation of medical evidence.
Use
What readers should do.
General information cannot account for an individual history, diagnosis, medication list, dose, or laboratory result.
Clinical decisions
Do not start, stop, replace, or change a medication or supplement because of this site alone. Bring the cited source and the page to a qualified clinician or pharmacist. Seek urgent care for emergency symptoms rather than using a supplement library.
Corrections
Found a safety issue?
Report it with the page URL, the disputed statement, and the best supporting source you have.